Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$378M |
| 2 |
AT&T
T
|
+$328M |
| 3 |
Roku
ROKU
|
+$326M |
| 4 |
Qualcomm
QCOM
|
+$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$255M |
Top Sells
| 1 |
Baidu
BIDU
|
+$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Pinduoduo
PDD
|
+$599M |
| 4 |
AbbVie
ABBV
|
+$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCBC
1101
DELISTED
Macatawa Bank Corp
MCBC
| $11.5M | 0.01% |
1,155,617
-78,204
| -6% | -$778K |
|
|
QIWI
1102
DELISTED
QIWI PLC
QIWI
| $11.5M | 0.01% |
1,079,250
+89,660
| +9% | +$955K |
|
|
ENZ
1103
DELISTED
Enzo Biochem, Inc.
ENZ
| $11.5M | 0.01% |
3,340,864
-215,359
| -6% | -$741K |
|
1104
Arrow Financial
AROW
$481M
| $11.5M | 0.01% |
376,832
-26,168
| -6% | -$798K |
|
1105
Sally Beauty Holdings
SBH
$1.5B
| $11.5M | 0.01% |
570,500
+11,600
| +2% | +$234K |
|
1106
CVB Financial
CVBF
$2.8B
| $11.5M | 0.01% |
519,581
-299,500
| -37% | -$6.62M |
|
1107
KKR & Co
KKR
$130B
| $11.5M | 0.01% |
234,850
-866,000
| -79% | -$42.3M |
|
1108
Apple Hospitality REIT
APLE
$2.98B
| $11.5M | 0.01% |
786,994
-1,387,200
| -64% | -$20.2M |
|
1109
VanEck Gold Miners ETF
GDX
$20.9B
| $11.5M | 0.01% |
352,800
+334,300
| +1,807% | +$10.9M |
|
1110
American Financial Group
AFG
$11.6B
| $11.5M | 0.01% |
100,400
+29,900
| +42% | +$3.41M |
|
|
VIA
1111
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $11.5M | 0.01% |
214,470
-12,600
| -6% | -$673K |
|
1112
Humana
HUM
$33.5B
| $11.4M | 0.01% |
27,288
-931,590
| -97% | -$391M |
|
1113
Old Second Bancorp
OSBC
$958M
| $11.4M | 0.01% |
861,125
-146,413
| -15% | -$1.93M |
|
1114
LifeVantage
LFVN
$144M
| $11.3M | 0.01% |
1,210,918
-38,887
| -3% | -$364K |
|
|
BRT
1115
BRT Apartments
BRT
$292M
| $11.3M | 0.01% |
672,191
-10,432
| -2% | -$176K |
|
|
ACBI
1116
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $11.3M | 0.01% |
469,324
-85,304
| -15% | -$2.06M |
|
|
HCCI
1117
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $11.3M | 0.01% |
416,000
-67,200
| -14% | -$1.82M |
|
1118
Cambium Networks
CMBM
$21.1M
| $11.2M | 0.01% |
240,700
-29,100
| -11% | -$1.36M |
|
|
SHI
1119
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $11.2M | 0.01% |
475,717
-31,700
| -6% | -$749K |
|
1120
CytomX Therapeutics
CTMX
$336M
| $11.2M | 0.01% |
1,452,568
-611,932
| -30% | -$4.73M |
|
1121
Centrus Energy
LEU
$4.16B
| $11.2M | 0.01% |
472,835
+61,200
| +15% | +$1.45M |
|
1122
Wingstop
WING
$7.69B
| $11.2M | 0.01% |
88,003
-261,500
| -75% | -$33.3M |
|
|
TPTX
1123
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $11.2M | 0.01% |
118,300
+84,200
| +247% | +$7.96M |
|
1124
Jack Henry & Associates
JKHY
$11.7B
| $11.2M | 0.01% |
73,619
-73,600
| -50% | -$11.2M |
|
1125
Celldex Therapeutics
CLDX
$1.65B
| $11.2M | 0.01% |
541,427
-507,400
| -48% | -$10.5M |
|